Cinclus Pharma Holding publ AB
CINPHA
CINPHA
Insider Trading Activity
Insider activity signal detected
2 activity signals detected for Cinclus Pharma Holding publ AB
Upgrade to see score, net flow, insiders and context.
Upgrade to see full signal details →Insider trades have triggered activity signals for Cinclus Pharma Holding publ AB. Upgrade to see score, net flow, insiders and the full signal context.
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2026-06-08 | 2026-06-08 | B Purchase |
Other senior executive Officer |
39,435
357.74
SEK4,741,789 |
39,435 | 357.74 | SEK4,741,789 | |
| 2026-06-05 | 2026-06-05 | B Purchase |
Other senior executive Officer |
1,554
405.28
SEK2,124,537 |
1,554 | 405.28 | SEK2,124,537 | |
| 2026-06-05 | 2026-06-04 | B Purchase |
Other member of the company's administrative, management or supervisory body |
25,899
190.11
SEK4,291,921 |
25,899 | 190.11 | SEK4,291,921 | |
| 2026-05-18 | 2026-05-15 | B Purchase |
Chief Financial Officer (CFO) Officer |
7,000
12.18
SEK85,260 |
7,000 | 12.18 | SEK85,260 | |
| 2026-04-09 | 2026-04-07 | B Purchase |
Chief Financial Officer (CFO) Officer |
6,500
16.10
SEK104,650 |
6,500 | 16.10 | SEK104,650 | |
| 2026-03-23 | 2026-03-20 | B Purchase |
Other member of the company's administrative, management or supervisory body Through Jesper Paul Fredrik Wiklund, a closely affiliated person |
6,000
17.97
SEK107,820 |
6,000 | 17.97 | SEK107,820 | |
| 2026-03-23 | 2026-03-19 | B Purchase |
Other member of the company's administrative, management or supervisory body Through Jesper Paul Fredrik Wiklund, a closely affiliated person |
5,600
18.40
SEK103,040 |
5,600 | 18.40 | SEK103,040 | |
| 2025-12-15 | 2025-12-11 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
29,000
17.13
SEK496,833 |
29,000 | 17.13 | SEK496,833 | |
| 2025-02-20 | 2025-02-20 | B Purchase |
Member of the Board of Directors Through PetoMaj Invest AB, a closely affiliated person Director |
40,000
15.90
SEK636,000 |
40,000 | 15.90 | SEK636,000 | |
| 2024-07-12 | 2024-07-12 | B Purchase |
Other senior executive Officer |
500
33.50
SEK16,750 |
500 | 33.50 | SEK16,750 | |
| 2024-06-25 | 2024-06-25 | B Purchase |
Member of the Board of Directors Director |
1,000
32.50
SEK32,500 |
1,000 | 32.50 | SEK32,500 | |
| 2024-06-25 | 2024-06-25 | B Purchase |
Other member of the company's administrative, management or supervisory body |
1,895
33.10
SEK62,724 |
1,895 | 33.10 | SEK62,724 | |
| 2024-06-26 | 2024-06-20 | B Purchase |
Member of the Board of Directors Director |
2,635
42.00
SEK110,670 |
2,635 | 42.00 | SEK110,670 | |
| 2024-06-24 | 2024-06-20 | B Purchase |
Member of the Board of Directors Through Peter Unge, a closely affiliated person Director |
25,450
39.19
SEK997,347 |
25,450 | 39.19 | SEK997,347 | |
| 2024-06-24 | 2024-06-20 | B Purchase |
Chairman of the Board of Directors Through PetoMaj Invest AB, a closely affiliated person Director |
2,021,075
42.00
SEK84,885,150 |
2,021,075 | 42.00 | SEK84,885,150 | |
| 2024-06-24 | 2024-06-20 | B Purchase |
Member of the Board of Directors Through PetoMaj Invest AB, a closely affiliated person Director |
13,075
42.00
SEK549,150 |
13,075 | 42.00 | SEK549,150 | |
| 2024-06-24 | 2024-06-20 | B Purchase |
Other member of the company's administrative, management or supervisory body |
1,970
42.00
SEK82,740 |
1,970 | 42.00 | SEK82,740 | |
| 2024-06-23 | 2024-06-20 | B Purchase |
Other member of the company's administrative, management or supervisory body |
1,450
42.00
SEK60,900 |
1,450 | 42.00 | SEK60,900 | |
| 2024-06-21 | 2024-06-20 | B Purchase |
Chairman of the Board of Directors Through PetoMaj Invest AB, a closely affiliated person Director |
2,021,075
42.00
SEK84,885,150 |
2,021,075 | 42.00 | SEK84,885,150 | |
| 2024-06-21 | 2024-06-20 | B Purchase |
Member of the Board of Directors Director |
2,490
42.00
SEK104,580 |
2,490 | 42.00 | SEK104,580 |
More insider trading research around Cinclus Pharma Holding publ AB
